These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18523390)

  • 1. Ultraviolet light exerts a major part of its therapeutic efficacy against vitiligo by production of prostaglandin E2.
    Namazi MR
    Dermatology; 2008; 217(2):149. PubMed ID: 18523390
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A.
    Bukhari IA
    Saudi Med J; 2005 Dec; 26(12):2011; author reply 2011. PubMed ID: 16380801
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose UVB therapy is comparable with conventional UVB phototherapy for treatment of vitiligo: A pilot study.
    Chiu SH; Liu IL; Chen YW; Lan CE
    J Dermatol Sci; 2018 Nov; 92(2):218-220. PubMed ID: 30227989
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultraviolet A in vitiligo.
    El-Mofty M; Mostafa W; Youssef R; El-Fangary M; Elramly AZ; Mahgoub D; Fawzy M
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):214-6. PubMed ID: 16869873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.
    De Francesco V; Stinco G; Laspina S; Parlangeli ME; Mariuzzi L; Patrone P
    Eur J Dermatol; 2008; 18(3):292-6. PubMed ID: 18474458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
    Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Ultraviolet Light on Vitiligo.
    Singh RK
    Adv Exp Med Biol; 2017; 996():55-60. PubMed ID: 29124690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo.
    Ganzetti G; Simonetti O; Campanati A; Giuliodori K; Offidani A
    Acta Derm Venereol; 2010 Nov; 90(6):642-3. PubMed ID: 21057754
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation study of the Vitiligo Extent Score-plus.
    van Geel N; Wolkerstorfer A; Lommerts JE; Ezzedine K; Eleftheriadou V; Hamzavi I; Harris J; Picardo M; Taieb A; Prinsen CAC; Bekkenk M; Speeckaert R
    J Am Acad Dermatol; 2018 May; 78(5):1013-1015. PubMed ID: 29180094
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial and molecular study of photoadaptation in vitiligo.
    Hexsel CL; Mahmoud BH; Mitchell D; Rivard J; Owen M; Strickland FM; Lim HW; Hamzavi I
    Br J Dermatol; 2009 Mar; 160(3):534-9. PubMed ID: 19067714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of narrowband ultraviolet B on hypertrophic scar in a patient having an isomorphic phenomenon and vitiligo.
    Oiso N; Kawara S; Kawada A
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1003-4. PubMed ID: 19522915
    [No Abstract]   [Full Text] [Related]  

  • 15. Narrowband ultraviolet B phototherapy for inflammatory vitiligo with raised borders associated with Sjögren's syndrome.
    Tanioka M; Takahashi K; Miyachi YI
    Clin Exp Dermatol; 2009 Apr; 34(3):418-20. PubMed ID: 19120387
    [No Abstract]   [Full Text] [Related]  

  • 16. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study.
    Wind BS; Kroon MW; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Meesters AA; Bos JD; Wolkerstorfer A
    Br J Dermatol; 2010 May; 162(5):1142-4. PubMed ID: 20199553
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.
    Benzekri L; Ezzedine K; Gauthier Y
    Br J Dermatol; 2013 May; 168(5):1143-6. PubMed ID: 23464539
    [No Abstract]   [Full Text] [Related]  

  • 18. Narrow-band ultraviolet B comb as an effective home-based phototherapy device for limited or localized non-segmental vitiligo: A pilot, open-label, single-arm clinical study.
    Khandpur S; Bhatia R; Bhadoria AS
    Indian J Dermatol Venereol Leprol; 2020; 86(3):298-301. PubMed ID: 32068191
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted UV therapy in the treatment of psoriasis.
    Stein KR; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2008; 19(3):141-5. PubMed ID: 17934935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylalanine and UVA for Vitiligo patients: probability of an effective treatment.
    Reuss S; Weiss C; Bayerl C
    Med Hypotheses; 2006; 67(1):199-200. PubMed ID: 16554122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.